Back to User profile » Dr George Wan

Papers published by Dr George Wan:


Adherence to Acthar Gel (RCI) and Outcomes in Patients with Membranous Nephropathy: A Claims Database Analysis

Hayes K, Fahim M, Hu FS, Panaccio MP, Wan GJ

ClinicoEconomics and Outcomes Research 2026, 18:530426

Published Date: 7 January 2026

Treatment Patterns and Outcomes of Acthar Gel in Ankylosing Spondylitis and Psoriatic Arthritis: A Physician-Reported Chart Review

Patel A, Shanbhag PP, Evans DR, Hayes K, Panaccio MP, Wan GJ

Open Access Rheumatology: Research and Reviews 2025, 17:193-202

Published Date: 11 September 2025

Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records

Bindra J, Chopra I, Hayes K, Niewoehner J, Panaccio MP, Wan GJ

Therapeutics and Clinical Risk Management 2024, 20:83-94

Published Date: 9 February 2024

Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis

Bindra J, Chopra I, Hayes K, Niewoehner J, Panaccio M, Wan GJ

ClinicoEconomics and Outcomes Research 2023, 15:739-752

Published Date: 17 October 2023

Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence

Wan GJ, Niewoehner J, Hayes K

ClinicoEconomics and Outcomes Research 2023, 15:499-512

Published Date: 26 June 2023

Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis

Hunter SF, Bindra J, Chopra I, Niewoehner J, Panaccio MP, Wan GJ

ClinicoEconomics and Outcomes Research 2021, 13:883-892

Published Date: 11 October 2021

Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis

Bindra J, Chopra I, Niewoehner J, Panaccio M, Wan GJ

ClinicoEconomics and Outcomes Research 2021, 13:349-358

Published Date: 6 May 2021